Three studies from UMCG in the Netherlands have found that adding a low dose of digoxin to standard heart failure treatment reduces hospital admissions by 25% and cardiovascular deaths by 19%.
← News
Medicine Breakthroughs Medicine Breakthroughs Health
Centuries-old medicine benefits heart failure patients, studies show
1,000 Study participants
3 Years Study duration
43 Research centers
Nature Medicine, JAMA Publication venues
ESC Barcelona Conference
<10¢ daily cost
19% mortality reduced
25% hospital admissions cut
500K+ heart failure patients affected